Sumit Aggarwal, Eloxx Pharmaceuticals president and CEO
Eloxx reports PhII cystic fibrosis fail as the biotech weighs its options
A rare disease biotech has fallen short in a clinical trial — and investors are none too happy about it.
Eloxx Pharmaceuticals reported Wednesday that its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
